Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-04

FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TROKENDI XR (topiramate) filed by Supernus Pharmaceuticals, Inc., updating the product's labeling to reflect the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TROKENDI XR (TOPIRAMATE)

Snippet

SUPPL AP for TROKENDI XR (TOPIRAMATE)